Form D · Biotechnology
Huya Bioscience International, LLC
San Diego, CA · CIK 0001461506
Offering snapshot reported Apr 22, 2015 · SEC filing
- Reported sold
- $48M Offering amount: $48M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Sep 27, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2015 | Initial | $48,000,000 | No comparison | 3 | SEC filing |
| Apr 2, 2012 | Initial | $7,613,268 | No comparison | 6 | SEC filing |
| Apr 7, 2009 | Initial | $5,000,025 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-238467
Total Offering Amount is the aggregate amount of convertible promissory notes that will convert into units.
Source: Form D, filed Apr 22, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mireille Gillings | Director, Executive |
| Mireille Gingras | Director, Executive |
| Clement Gingras | Director, Executive |
| Robert M. Haimsohn | Director |
| Sabrina Martucci Johnson | Executive |
| Michael Mortimer | Director |
| John Sharp | Executive |
| Derek Winstanley | Executive |
| Derek Winstanly | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12531 High Bluff Drive Suite 138
San Diego, CA, 92130
San Diego, CA, 92130